Jonathan B. Baell

Nanjing Tech University — China

Materials Science · Physical Sciences

52h-index15.0kcitations347works2.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Crystallization and Solubility Studies(39), X-ray Diffraction in Crystallography(38), Computational Drug Discovery Methods(37), Trypanosoma species research and implications(29), Research on Leishmaniasis Studies(23)

Publications347 total

Electrochemical β-Lactam Probes for Rapid Detection of β-Lactamases: From Solution-Phase Activation toward Surface-Integrated Biosensing
Journal of the American Chemical Society·2026
Biological Activity and Structural Biology of Current KAT6A Inhibitor Chemotypes
Journal of Medicinal Chemistry·2026Open Access
Promiscuously bioactive compounds are prevalent in widely used commercial drug repurposing libraries
European Journal of Medicinal Chemistry·2025
Fluorinated pyrimidine 5-carboxamides as potential tools for MERTK targeted fluorine-18-PET-radioligand development
RSC Medicinal Chemistry·2025Open Access
Formylpeptide receptors: A novel target to treat cardiometabolic complications
Pharmacology & Therapeutics·2025Open Access
Nitroreductase-Activated Probes for Monitoring Hypoxia
ACS Sensors·2025· 1 cited
Development of potent glutathione transferase Omega-1 inhibitors with applications in inflammation and cancer therapy
European Journal of Medicinal Chemistry·2025· 1 citedOpen Access
Dual inhibition of AXL and MER kinase: scope for lung and breast cancer therapeutics
Bioorganic Chemistry·2025
Discovery of WEE1 Kinase Inhibitors with Potent Activity against Patient-Derived, Metastatic Colorectal Cancer Organoids
Journal of Medicinal Chemistry·2025· 3 cited
Unlocking pH-responsive dual payload release through hydrazone linkage chemistry
Bioorganic & Medicinal Chemistry·2025· 4 citedOpen Access
Platform of Oxidative Transformation of α-Methyl Secondary Enaminones toward Tetrahydropyridines
The Journal of Organic Chemistry·2025
Heterocyclic core modifications in trypanosomacidal 2-[(phenylheteroaryl)ethyl]ureas
RSC Medicinal Chemistry·2025Open Access
Author response for "Heterocyclic Core Modifications in Trypanosomacidal 2-[(Phenylheteroaryl)ethyl]ureas"
2024
A Collection of Useful Nuisance Compounds (CONS) for Interrogation of Bioassay Integrity
JACS Au·2024· 2 citedOpen Access
Tolfenpyrad Derivatives Exhibit Potent <i>Francisella</i>-Specific Antibacterial Activity without Toxicity to Mammalian Cells <i>In Vitro</i>
ACS Infectious Diseases·2024· 1 cited
The benefits of translating biomedical research at drug discovery institutes
Nature Reviews Drug Discovery·2024
Synthesis of Tetrahydropyridines from α-Methyl Enaminones as the Sole Reactants by the Inverse-electron Demand Het-ero-Diels-Alder Reactions under Mild, Catalyst-free, and Step-economic Conditions
2024Open Access
Phenotypic‐Based Discovery and Exploration of a Resorufin Scaffold with Activity against <i>Mycobacterium tuberculosis</i>
ChemMedChem·2024· 1 citedOpen Access
Novel Diacyl-hydrazide Compounds as Potential Therapeutics for Visceral Leishmaniasis
ACS Omega·2024· 4 citedOpen Access
Biased receptor signalling and intracellular trafficking profiles of structurally distinct formylpeptide receptor 2 agonists
British Journal of Pharmacology·2024· 10 citedOpen Access
page 1 of 18Next →

Frequent Co-authors

Ian P. Street(7), Vicky M. Avery(7), Jayme L. Dahlin(6), Michael A. Walters(5), John P. Parisot(5), Nghi Nguyen(5), Raphaël Rahmani(4), Brad E. Sleebs(4), Kym N. Lowes(4), David C.S. Huang(4), Olan Dolezal(4), Hendrik Falk(4), Thomas S. Peat(4), Sandra Duffy(4), C.H. Arrowsmith(3), Peter J. Brown(3), J. Willem M. Nissink(3), Guillaume Lessène(3), Peter E. Czabotar(3), Hong Yang(3)